When was Shengshi Technology founded?

Shengshi Technology was founded in 2017 and raised its 1st funding round 5 years after it was founded.

Where is Shengshi Technology located?

Shengshi Technology is headquartered in Hangzhou, China.

Is Shengshi Technology a funded company?

Shengshi Technology is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Jan 05, 2022.

When was the latest funding round of Shengshi Technology?

Shengshi Technology's latest funding was a $***** Seed round on Jan 05, 2022, with participation from 3 investors.

Where does Shengshi Technology rank among its competitors?

Shengshi Technology ranks 31st amongst 51 active competitors, of which 8 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was dātma, which secured $2.5M in Dec, 2024.

Who are the top competitors of Shengshi Technology?

Shengshi Technology's top competitors include Coriell Life Sciences, Omega Therapeutics and BAMF Health. Among them, dātma secured the most recent funding round in December, 2024.

Shengshi Technology - 2026 Company Profile, Funding & Competitors

Shengshi Technology is a seed company based in Hangzhou (China), founded in 2017. It operates as an AI and cloud-based precision diagnosis tool for healthcare professionals. Shengshi Technology has raised an undisclosed amount in funding from Yuanbio Venture Capital. The company has 51 active competitors, including 8 funded and 4 that have exited. Its top competitors include companies like Coriell Life Sciences, Omega Therapeutics and BAMF Health.

Company Details

AI and cloud-based precision diagnosis tool for healthcare professionals. The company has developed software that assists with treatment planning and management. It has features for disease diagnosis, data analysis, dynamics numerical simulation, and more.

Website: www.4dmedvision.com
Email ID: *****@4dmedvision.com
Phone Number: +86 **********

Key Metrics

Founded Year

2017

Location

Hangzhou, China

Stage

Seed

Latest Funding Round

Seed, Jan 05, 2022, $*****

Investors

Yuanbio Venture Capital & 2 more

Ranked

31^st among 51 active competitors

Similar Companies

Coriell Life Sciences & 70 more

View Shengshi Technology's full profile

Shengshi Technology has raised funding over 1 round. Its latest funding round was a Seed round on Jan 05, 2022 for $*****. 3 investors participated in its latest round. Shengshi Technology has 3 institutional investors.

Here is the list of recent funding rounds of Shengshi Technology:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 05, 2022	1362648	Seed	2265542	9388821	2793696	3301282

Access funding benchmarks and valuations. Sign up today!

View details of Shengshi Technology's funding rounds and investors

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Shengshi Technology include Coriell Life Sciences, Omega Therapeutics and BAMF Health. Here is the list of Top 10 competitors of Shengshi Technology, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Coriell Life Sciences 2013, Camden (United States), Acquired	Provider of precision medicine tools for clinicians	$10.1M	-	53/100
2nd	Omega Therapeutics 2016, Cambridge (United States), Public	Provider of platform for human genome study for precision medicine	$211M	Flagship Pioneering, Logos & 9 others	52/100
3rd	BAMF Health 2018, Grand Rapids (United States), Series A	Developer of AI-enabled molecular imaging and theranostics	$4M	New Community Transformation Fund, Corewell Health Ventures ... & 1 others	51/100
4th	LifeOmic 2016, Indianapolis (United States), Acquired	Storage, management and analysis of omic data for health applications	-	-	46/100
5th	dātma 2016, Beaverton (United States), Seed	Provider of software to clinics for decision-making and omics data automation	$2.5M	Generator Ventures, National Science Foundation	45/100
6th	Aranscia 2022, Houston (United States), Unfunded	Provider of human-first diagnostic solutions for clinical professionals and diagnostic labs	-	-	43/100
7th	InpharmD 2014, Atlanta (United States), Seed	Online medical assistant for providers decision support system	$6.62M	645 Ventures, Y Combinator & 3 others	35/100
8th	Decode Health 2013, Nashville (United States), Unfunded	Precision medicine analytics platform for pharmaceutical, diagnostic, and technology companies	-	-	34/100
9th	OmicMD 2017, Seattle (United States), Unfunded	AI platform revolutionizing multi-omic therapy design and treatment optimization	-	-	32/100
10th	BasePair Genomics 2018, Hawthorn (Australia), Unfunded	Provider of diagnostic tests and genetic testing services	-	-	32/100
31st	Shengshi Technology 2017, Hangzhou (China), Seed	AI and cloud-based precision diagnosis tool for healthcare professionals	-	Yuanbio Venture Capital, BMC & 1 others	23/100